Clinical Trials on Conjunctivitis, Bacterial in New Zealand

Total 2025 results

Bausch & Lomb Incorporated

Terminated

Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Bausch & Lomb Incorporated

Terminated

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle

Bacterial Conjunctivitis

United States
Merck Sharp & Dohme LLC

Completed

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

Bacterial Conjunctivitis

United States
Merck Sharp & Dohme LLC

Completed

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

Bacterial Conjunctivitis

United States
NovaBay Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis (BACTOvation™)

Bacterial Conjunctivitis

United States
Okogen

Active, not recruiting

OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis (RUBY)

Adenoviral Conjunctivitis

Australia
Shire

Terminated

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

Acute Adenoviral Conjunctivitis

United States
Shire

Completed

Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo

Bacterial Conjunctivitis

United States, Australia, Austria, Israel, Poland, Hungary, South Africa, Canada, Estonia, France, Italy, Spain, Puerto Rico
NovaBay Pharmaceuticals, Inc.

Completed

Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis (BAYnovation™)

Adenoviral Conjunctivitis

United States, India, Brazil, Sri Lanka
Shire

Terminated

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo

Adenoviral Conjunctivitis

United States, Puerto Rico
Capital and Coast District Health board
Wellington Southern Community Laboratories; Institute of Environmental Science...

Recruiting

Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.

Bacterial Infections

New Zealand
Shire

Terminated

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

Adenoviral Conjunctivitis

United States, Israel, France, India, Australia, Austria, Spain, Estonia, Hungary, Poland, South Africa, Canada, Germany, Italy, Peru, United Kingdom
Allergan

Completed

Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

Atopic Conjunctivitis

Canada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
Endologix

Completed

PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass (PQB4FP1)

Peripheral Arterial Disease

New Zealand
Avinger, Inc.

Withdrawn

Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries (COMBINE-II)

Peripheral Arterial Disease

New Zealand
AmtixBio Co., Ltd.
Novotech (Australia) Pty Limited

Completed

A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis

Onychomycosis

New Zealand
AmtixBio Co., Ltd.

Not yet recruiting

A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis

Onychomycosis

New Zealand
Terumo Medical Corporation

Recruiting

Kaitoh Atherectomy FIH

Peripheral Arterial Disease

New Zealand
W.L.Gore & Associates

Completed

Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX)

Peripheral Arterial Disease | Common Iliac Artery Occlusive Disease | External Iliac Artery Occlusive Disease

New Zealand
Spectranetics Corporation

Completed

Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries: (PK)

Peripheral Artery Disease

New Zealand
Ellume Pty Ltd

Withdrawn

Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis

Group A Streptococcal Infection

New Zealand
Starship Child Health, Te Toka Tumai Auckland
Menzies School of Health Research; Health Research Council, New Zealand

Not yet recruiting

TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children (TREAT-SC)

Rheumatic Fever | Sydenham Chorea

Australia, New Zealand
TriReme Medical, LLC

Completed

Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial (ENDURE)

Peripheral Vascular Disease

New Zealand, Germany
Lihir Medical Centre
London School of Hygiene and Tropical Medicine

Completed

Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )

Yaws | Scabies | Lymphatic Filariases | Trachoma | Strongyloidiasis

Papua New Guinea
Medtronic Vascular

Completed

Bare Metal Bifurcation Stent Clinical Trial in Humans (BRANCH)

Myocardial Ischemia | Coronary Artery Disease

New Zealand
Shockwave Medical, Inc.

Active, not recruiting

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

Peripheral Arterial Disease

New Zealand, Australia
The University of New South Wales

Terminated

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

Ischemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTA

New Zealand, Australia, Netherlands
Bausch & Lomb Incorporated

Completed

Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge

Allergic Conjunctivitis

United States
Sutphin Drugs

Unknown

To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension

Blepharo Conjunctivitis

United States
NeuroActiva, Inc.

Completed

A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831

Neurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive Disorder

New Zealand
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Starx Research Center, LLC

Unknown

Ocular Allergy Treatment Practical Impact Trial ((OAT-PIT))

Allergic Conjunctivitis | Rhinoconjunctivitis

United States
Cagent Vascular LLC

Completed

PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE (PRELUDE)

Peripheral Arterial Disease

New Zealand, Austria, Poland
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Coronary Artery Disease

New Zealand, Belgium
Efemoral Medical, Inc.

Recruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery (Efemoral I)

Vascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal Stenosis

New Zealand, Australia
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
Shockwave Medical, Inc.

Completed

Safety and Performance Study of the Shockwave Lithoplasty System (DISRUPT-PAD)

Peripheral Arterial Disease

Austria, Germany, New Zealand
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Amplitude Vascular Systems, Inc.

Active, not recruiting

POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling (POWER-PAD-1)

Peripheral Arterial Disease

Australia, New Zealand, Dominican Republic
ReFlow Medical, Inc.
ClinLogix. LLC

Active, not recruiting

A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee (DEEPER OUS)

Peripheral Arterial Disease

New Zealand, Germany, Switzerland
Biotronik CRC Inc.
Biotronik AG

Active, not recruiting

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Murdoch Childrens Research Institute
Royal Children's Hospital

Completed

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

Primary Immunodeficiency | Invasive Pneumococcal Disease, Protection Against | Invasive Pneumococcal Disease, Recurrent Isolated, 1 | Invasive Pneumococcal Disease, Recurrent Isolated, 2

Australia, New Zealand
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
Shockwave Medical, Inc.

Completed

Safety and Feasibility of the Shockwave Lithoplasty® System for the Treatment of Peripheral Vascular Stenosis (BTK)

Peripheral Arterial Disease

New Zealand, Austria, Germany
Elixir Medical Corporation

Completed

DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

Coronary Artery Disease

New Zealand
Cook Group Incorporated

Completed

Zilver PTX Delivery System

Peripheral Vascular Disease

New Zealand, Australia, Germany
Shockwave Medical, Inc.

Completed

Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)

Peripheral Arterial Disease

New Zealand, Germany, Austria
University of Rochester

Completed

Moxifloxacin vs. Polytrim for Conjunctivitis

Conjunctivitis

United States

Clinical Trials on Conjunctivitis, Bacterial in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations